List of Tables
    Table 1. Non-oncology Biopharmaceuticals Market Opportunities & Trends in Global Market
    Table 2. Non-oncology Biopharmaceuticals Market Drivers in Global Market
    Table 3. Non-oncology Biopharmaceuticals Market Restraints in Global Market
    Table 4. Key Players of Non-oncology Biopharmaceuticals in Global Market
    Table 5. Top Non-oncology Biopharmaceuticals Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Non-oncology Biopharmaceuticals Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Non-oncology Biopharmaceuticals Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Non-oncology Biopharmaceuticals Product Type
    Table 9. List of Global Tier 1 Non-oncology Biopharmaceuticals Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Non-oncology Biopharmaceuticals Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Non-oncology Biopharmaceuticals Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Non-oncology Biopharmaceuticals Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Non-oncology Biopharmaceuticals Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Non-oncology Biopharmaceuticals Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Non-oncology Biopharmaceuticals Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Non-oncology Biopharmaceuticals Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Non-oncology Biopharmaceuticals Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Non-oncology Biopharmaceuticals Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Non-oncology Biopharmaceuticals Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Non-oncology Biopharmaceuticals Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Non-oncology Biopharmaceuticals Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Non-oncology Biopharmaceuticals Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Non-oncology Biopharmaceuticals Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Non-oncology Biopharmaceuticals Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Non-oncology Biopharmaceuticals Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Non-oncology Biopharmaceuticals Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Non-oncology Biopharmaceuticals Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Non-oncology Biopharmaceuticals Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Non-oncology Biopharmaceuticals Revenue, (US$, Mn), 2023-2028
    Table 30. Roche Corporate Summary
    Table 31. Roche Non-oncology Biopharmaceuticals Product Offerings
    Table 32. Roche Non-oncology Biopharmaceuticals Revenue (US$, Mn), (2017-2022)
    Table 33. Sanofi Corporate Summary
    Table 34. Sanofi Non-oncology Biopharmaceuticals Product Offerings
    Table 35. Sanofi Non-oncology Biopharmaceuticals Revenue (US$, Mn), (2017-2022)
    Table 36. Johnson & Johnson Corporate Summary
    Table 37. Johnson & Johnson Non-oncology Biopharmaceuticals Product Offerings
    Table 38. Johnson & Johnson Non-oncology Biopharmaceuticals Revenue (US$, Mn), (2017-2022)
    Table 39. Pfizer Corporate Summary
    Table 40. Pfizer Non-oncology Biopharmaceuticals Product Offerings
    Table 41. Pfizer Non-oncology Biopharmaceuticals Revenue (US$, Mn), (2017-2022)
    Table 42. Novo Nordisk Corporate Summary
    Table 43. Novo Nordisk Non-oncology Biopharmaceuticals Product Offerings
    Table 44. Novo Nordisk Non-oncology Biopharmaceuticals Revenue (US$, Mn), (2017-2022)
    Table 45. Novartis Corporate Summary
    Table 46. Novartis Non-oncology Biopharmaceuticals Product Offerings
    Table 47. Novartis Non-oncology Biopharmaceuticals Revenue (US$, Mn), (2017-2022)
    Table 48. Merck Corporate Summary
    Table 49. Merck Non-oncology Biopharmaceuticals Product Offerings
    Table 50. Merck Non-oncology Biopharmaceuticals Revenue (US$, Mn), (2017-2022)
    Table 51. Teva Corporate Summary
    Table 52. Teva Non-oncology Biopharmaceuticals Product Offerings
    Table 53. Teva Non-oncology Biopharmaceuticals Revenue (US$, Mn), (2017-2022)
    Table 54. Eli Lilly Corporate Summary
    Table 55. Eli Lilly Non-oncology Biopharmaceuticals Product Offerings
    Table 56. Eli Lilly Non-oncology Biopharmaceuticals Revenue (US$, Mn), (2017-2022)
    Table 57. Bristol-Myers Squibb Corporate Summary
    Table 58. Bristol-Myers Squibb Non-oncology Biopharmaceuticals Product Offerings
    Table 59. Bristol-Myers Squibb Non-oncology Biopharmaceuticals Revenue (US$, Mn), (2017-2022)
    Table 60. GlaxoSmithKline Corporate Summary
    Table 61. GlaxoSmithKline Non-oncology Biopharmaceuticals Product Offerings
    Table 62. GlaxoSmithKline Non-oncology Biopharmaceuticals Revenue (US$, Mn), (2017-2022)
    Table 63. UCB Pharma Corporate Summary
    Table 64. UCB Pharma Non-oncology Biopharmaceuticals Product Offerings
    Table 65. UCB Pharma Non-oncology Biopharmaceuticals Revenue (US$, Mn), (2017-2022)
    Table 66. Amgen Corporate Summary
    Table 67. Amgen Non-oncology Biopharmaceuticals Product Offerings
    Table 68. Amgen Non-oncology Biopharmaceuticals Revenue (US$, Mn), (2017-2022)
    Table 69. AbbVie Corporate Summary
    Table 70. AbbVie Non-oncology Biopharmaceuticals Product Offerings
    Table 71. AbbVie Non-oncology Biopharmaceuticals Revenue (US$, Mn), (2017-2022)
    Table 72. Takeda Corporate Summary
    Table 73. Takeda Non-oncology Biopharmaceuticals Product Offerings
    Table 74. Takeda Non-oncology Biopharmaceuticals Revenue (US$, Mn), (2017-2022)
    Table 75. AstraZeneca Corporate Summary
    Table 76. AstraZeneca Non-oncology Biopharmaceuticals Product Offerings
    Table 77. AstraZeneca Non-oncology Biopharmaceuticals Revenue (US$, Mn), (2017-2022)
    Table 78. Mylan Corporate Summary
    Table 79. Mylan Non-oncology Biopharmaceuticals Product Offerings
    Table 80. Mylan Non-oncology Biopharmaceuticals Revenue (US$, Mn), (2017-2022)
    Table 81. LEO Pharma Corporate Summary
    Table 82. LEO Pharma Non-oncology Biopharmaceuticals Product Offerings
    Table 83. LEO Pharma Non-oncology Biopharmaceuticals Revenue (US$, Mn), (2017-2022)
    Table 84. Boehringer Ingelheim Corporate Summary
    Table 85. Boehringer Ingelheim Non-oncology Biopharmaceuticals Product Offerings
    Table 86. Boehringer Ingelheim Non-oncology Biopharmaceuticals Revenue (US$, Mn), (2017-2022)
    Table 87. Alexion Pharmaceuticals Corporate Summary
    Table 88. Alexion Pharmaceuticals Non-oncology Biopharmaceuticals Product Offerings
    Table 89. Alexion Pharmaceuticals Non-oncology Biopharmaceuticals Revenue (US$, Mn), (2017-2022)
    Table 90. Elusys Therapeutics Corporate Summary
    Table 91. Elusys Therapeutics Non-oncology Biopharmaceuticals Product Offerings
    Table 92. Elusys Therapeutics Non-oncology Biopharmaceuticals Revenue (US$, Mn), (2017-2022)
    Table 93. Swedish Orphan Biovitrum Corporate Summary
    Table 94. Swedish Orphan Biovitrum Non-oncology Biopharmaceuticals Product Offerings
    Table 95. Swedish Orphan Biovitrum Non-oncology Biopharmaceuticals Revenue (US$, Mn), (2017-2022)
    Table 96. Biogen Corporate Summary
    Table 97. Biogen Non-oncology Biopharmaceuticals Product Offerings
    Table 98. Biogen Non-oncology Biopharmaceuticals Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Non-oncology Biopharmaceuticals Segment by Type in 2021
    Figure 2. Non-oncology Biopharmaceuticals Segment by Application in 2021
    Figure 3. Global Non-oncology Biopharmaceuticals Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Non-oncology Biopharmaceuticals Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Non-oncology Biopharmaceuticals Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Non-oncology Biopharmaceuticals Revenue in 2021
    Figure 8. By Type - Global Non-oncology Biopharmaceuticals Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Non-oncology Biopharmaceuticals Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Non-oncology Biopharmaceuticals Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Non-oncology Biopharmaceuticals Revenue Market Share, 2017-2028
    Figure 12. US Non-oncology Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Non-oncology Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Non-oncology Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Non-oncology Biopharmaceuticals Revenue Market Share, 2017-2028
    Figure 16. Germany Non-oncology Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
    Figure 17. France Non-oncology Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Non-oncology Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Non-oncology Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Non-oncology Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Non-oncology Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Non-oncology Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Non-oncology Biopharmaceuticals Revenue Market Share, 2017-2028
    Figure 24. China Non-oncology Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Non-oncology Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Non-oncology Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Non-oncology Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
    Figure 28. India Non-oncology Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Non-oncology Biopharmaceuticals Revenue Market Share, 2017-2028
    Figure 30. Brazil Non-oncology Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Non-oncology Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Non-oncology Biopharmaceuticals Revenue Market Share, 2017-2028
    Figure 33. Turkey Non-oncology Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Non-oncology Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Non-oncology Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Non-oncology Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
    Figure 37. Roche Non-oncology Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Sanofi Non-oncology Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Johnson & Johnson Non-oncology Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Pfizer Non-oncology Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Novo Nordisk Non-oncology Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Novartis Non-oncology Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Merck Non-oncology Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Teva Non-oncology Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Eli Lilly Non-oncology Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Bristol-Myers Squibb Non-oncology Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 47. GlaxoSmithKline Non-oncology Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 48. UCB Pharma Non-oncology Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 49. Amgen Non-oncology Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 50. AbbVie Non-oncology Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 51. Takeda Non-oncology Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 52. AstraZeneca Non-oncology Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 53. Mylan Non-oncology Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 54. LEO Pharma Non-oncology Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 55. Boehringer Ingelheim Non-oncology Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 56. Alexion Pharmaceuticals Non-oncology Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 57. Elusys Therapeutics Non-oncology Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 58. Swedish Orphan Biovitrum Non-oncology Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 59. Biogen Non-oncology Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2017-2022)